Company / Operating Cash Flow
Cocrystal Pharma, Inc. Operating Cash Flow History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$12.7M
FY2021
5-year range
-$12.7M / -$1.6M
FY2017-FY2021
Trend
-713.8%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow changed -714% YoY in FY2021, a notable deviation from the 3-year average annual change of -351%.
Based on SEC 10-K filings.
-$13M in FY2021.
Declined from -$8M to -$13M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating cash flow decreased 713.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$12.7M | -713.8% |
| FY2020 | -$1.6M | +81.1% |
| FY2019 | -$8.3M | -421.8% |
| FY2012 | -$1.6M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026